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Abstract 
Background: Respiratory distress syndrome 
(RDS) is the principal cause of early neonatal 
morbidity and mortality.  
Objective: The current study aims to evaluate 
the effect of dexamethasone administration 48 
hours before elective cesarean section (CS) at 
term on neonatal respiratory morbidity. 
Methods: The current study was a case-control 
study conducted between June 2015 and 
November 2015. Women who attended the labor 
ward in Sohag University Hospital, Egypt, after 
37 weeks of gestation for elective CS were 
approached for participation. The patients 
received 2 intramuscular doses of 12 mg 
dexamethasone 12 hours apart in the 48 hours 
before CS (N=246). The control group included 
women who did not receive dexamethasone 
before CS during the same period of the study 
(N=275).  
Results: No significant differences were 
detected between the study and control groups 
with regard to age, parity or gestational age at 
delivery. There was a significantly higher 
number of neonates with RDS and transient 
tachypnea in the control group compared to the 
study group (p=0.001). The rate of neonatal 
admission to the neonatal care unit (NICU) was 
significantly lower in the study group (p=0.001). 
Conclusions: Prophylactic dexamethasone 
administration before elective CS at term 
significantly reduces neonatal respiratory 
morbidity and admission to NICU. 
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Introduction 
Respiratory distress syndrome (RDS) is 
the principal cause of early neonatal 
morbidity and mortality and significantly 
contributes to high costs of neonatal 
intensive care.1 
Infants born by elective caesarean 
section (CS) at term are more likely to 
develop respiratory morbidity than 
infants born vaginally.2 Elective CS 
compared with intended vaginal delivery 
Proceedings in Obstetrics and Gynecology, 2016;6(3):2 
 
Dexamethasone before elective cesarean section at term 2 
 
(VD) leads to a two-fold to four-fold 
increased risk of overall neonatal 
respiratory morbidity and even higher 
relative risks of serious respiratory 
morbidity in term newborns.3 Maternal 
steroid treatment before preterm 
delivery is one of the best documented 
and most cost-effective and life-saving 
treatments in prenatal medicine.4,5 
No serious side effects have been 
reported after administration of 
corticosteroids during pregnancy, but 
some studies reported a reduction in 
fetal body movements, fetal breathing 
movements and heart rate variation 
after betamethasone administration.6,7 
Antenatal corticosteroids for term CS 
may lead to a reduction in morbidity in 
babies delivered by CS at term. 
However, the evidence for the 
administration of corticosteroids after 37 
weeks is still controversial.2 
Betamethasone given before elective 
CS at term reduces respiratory distress 
and admission to pediatric care units.8 
This is of great importance for 
developing countries where resources 
are scarce and it is often difficult to 
provide expensive treatments such as 
neonatal care.  
Based on high-grade evidence, 
antenatal corticosteroid therapy is very 
effective in preventing neonatal 
respiratory mortality and morbidity, yet 
remains at low coverage in low/middle-
income countries.9The current study 
aimed to evaluate the effect of 
prophylactic dexamethasone 
administration before elective CS at 
term on neonatal respiratory morbidity. 
 
Patients and methods 
Study setting and design 
The current study was a prospective 
non-randomized clinical study 
conducted between June 2015 and 
November 2015. The study participants 
were recruited from the labor ward of 
Sohag University Hospital in Egypt. The 
institutional ethical review board 
approved the study. 
Study participants 
All pregnant women who presented to 
the above hospital for elective CS after 
37 weeks gestation, based on their 
reliable dates and confirmed by early 
ultrasound measurement of crown rump 
length, were included in the study. 
Informed written consent was obtained 
for participation after reading the patient 
information sheet or having it discussed 
with patients that were illiterate.  
We included in our study pregnant 
women with a singleton pregnancy, 
gestational age after 37 weeks, no 
medical disorders or obstetric 
complications during the current 
pregnancy and absence of uterine 
contractions before the CS.  
We excluded women with obstetric 
complications including preeclampsia, 
diabetes mellitus (DM), antepartum 
hemorrhage, known fetal anomaly, twin 
pregnancy, intrauterine growth 
restriction and premature ruptured 
membranes. Also, women who declined 
to participate in the study were 
excluded.  
All study participants underwent an 
ultrasound examination before inclusion 
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to ensure the date and exclude the 
presence of multiple gestations, 
intrauterine growth restriction, 
oligohydramnios, polyhydramnios and 
any congenital fetal malformations. 
Study intervention 
Dexamethasone administration before 
elective CS at term is not routinely 
practiced in the aforementioned 
hospital. The decision depends on the 
local protocols of the hospital units 
working in the daily shifts. So, all eligible 
participants were allocated to one of the 
following groups 
• Group I (study group): included 
women who had received two 
intramuscular doses of 12 mg 
dexamethasone 
(Dexamethasone 8 ml, Sigma)12 
hours apart, 48 hours before 
elective CS. 
• Group II (control group): 
included women who did not 
receive the scheduled dose taken 
as a control group. 
Follow-up schedule 
All study participants were 
anaesthetized spinally by a senior 
resident of anesthesia, and the elective 
CS was done by a senior resident of 
obstetrics. All deliveries were attended 
by a neonatology specialist; details of 
the resuscitation at the operative theatre 
were recorded. Apgar scores at 1 and 5 
minutes were recorded. All neonates 
were assessed for signs of RDS 
[defined as the presence of at least 2 of 
the following criteria: tachypnea, central 
cyanosis in room air, expiratory grunting 
and subcostal, intercostal or jugular 
retraction and nasal flaring]10 or 
transient tachypnea of newborn (TTN) 
[defined as a period of rapid breathing 
higher than the normal range of 40-60 
times per minute].11All neonates 
admitted to NICU were subjected to 
chest X-ray for exclusion of other 
associated pathologies and confirmation 
of diagnosis of RDS. All data about the 
need for admission to neonatal intensive 
care unit (NICU) or the need for 
mechanical ventilation within 24 hours 
after birth were recorded. 
Study outcomes 
The primary outcome of this study was 
the incidence of neonatal RDS. The 
secondary outcomes included the 
incidence of TTN, incidence of 
admission to NICU and lastly the need 
for mechanical ventilation within 24 
hours after birth. 
Statistical analysis 
The data were collected and analyzed 
using the Statistical Package for Social 
Science (IBM, SPSS Inc., Chicago, 
version 21).The demographic data were 
compared between groups. A Student 
T-test was used to compare the 
continuous outcome measures. For 
dichotomous variables, chi-square was 
used to estimate the significance value. 
For analysis, P<0.05 was considered to 
be significant. 
Results  
Out of 591 pregnant women scheduled 
for elective CS during the study period, 
521 of them were enrolled in the study. 
The causes of exclusion as well as the 
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study flowchart are shown in Figure 1.  
 
 
  
  
 
 
 
 
 
 
   
   
  
 
    
   
Figure 1: The study flowchart 
There were no significant differences 
between the two groups regarding their 
age, parity, number of previous 
miscarriages, gestational age at delivery 
and body mass index at the time of 
enrollment (Table 1).          
591women evaluated for participation in the study 
Excluded Cases (n=70) 
 
DM               27 
Hypertension    24 
Twins 9 
Refuse        10 
 
 
 
 
 
Included 521 cases 
Allocation 
Control group (II) n=275 
Didn’t receive 
dexamethasone before 
elective CS  
Study group (I) n=246 
Received 2 doses of 12 
mg dexamethasone 
before elective CS 
Follow-up 
 
Control group (II) n=275 
  
Study group (I) n=246 
 
Neonatal assessment by Apgar score, clinical examination for signs of 
respiratory morbidity, need for admission to neonatal intensive care unit, 
and mechanical ventilation. 
 
Analysis 
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Table 1: The demographic characteristics of the study participants 
 
Variables Group I 
(study group) 
n=246 
Group II 
(control group)  
n=275 
p-value 
Age (years),mean±SD 28.45 ± 6.17 29.86 ± 5.9 0.225 
Parity, mean±SD 2.47 ± 1.61 2.15 ± 1.79 0.092 
Previous miscarriages, median (range) 1 (0-4) 2 (0-4) 0.329 
BMI (Kg/m2),mean±SD 24.2 ± 4.6 25.3 ± 4.3 0.42 
Gestational age at delivery (weeks),mean±SD 38.7± 1.58 38.55 ± 1.63 0.164 
Indications of CS, n (%) 
     Repeat CS 
     CS on request 
     Breech presentation 
     Cephalopelvic disproportion 
     Others 
 
142 (57.7%) 
54 (22%) 
21 (8.5%) 
15 (6.1%) 
14 (5.7%) 
 
161 (58.5%) 
68 (24.7%) 
24 (8.7%) 
13 (4.7%) 
9 (3.3%) 
0.866 
BMI; body mass index, CS; cesarean section, SD; standard deviation  
 
There were no significant differences 
between the two groups with regard to 
neonatal birth weight and gender. There 
were significantly higher Apgar scores at 
1 and 5 minutes after delivery in the 
study group (Group I) (p=0.0001 and 
0.011 respectively) (Table 2). 
Table 2: The neonatal outcome of the two study groups 
 
Variables Group I 
(study group)  
n=246 
Group II 
 (control group)  
n=275 
p-value 
Neonatal gender, n (%) 
     Male  
     Female 
 
139 (56.5%) 
107 (43.5%) 
 
143 (52%) 
132 (48%) 
 
0.19 
Birth weight, mean±SD (range) 3035.6 ± 231.17 
(2560 – 3750) 
3095.74 ± 249.2 
(2670 – 3820) 
0.832 
Apgar score, mean±SD 
     At 1 minute 
     At 5 minutes 
 
8.63 ± 1.4 
9.62 ± 0.33 
 
6.95 ± 2.24 
8.37 ± 1.19 
 
0.0001 
0.011 
Neonatal respiratory morbidity, n (%) 
     RDS 
     TTN 
 
2 (0.8%) 
5 (2%) 
 
13 (4.7%) 
41 (14.9%) 
 
0.001 
0.001 
Admission to NICU, n (%) 7 (2.8%) 35 (12.7%) 0.003 
Mechanical ventilation, n (%) 2 (0.8%) 10 (3.6%) 0.027 
CPAP, n (%) 5 (2%) 25 (9.1%) 0.0001 
Nasal oxygen, n (%) 0 19 (6.9%) ------ 
RDS; respiratory distress syndrome, TTN; transient tachypnea of newborn, NICU; neonatal intensive care unit, 
CPAP; continuous positive airway pressure ventilation, SD; standard deviation 
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Regarding the primary outcome of the 
study, the incidence of RDS was 
significantly higher in the control group 
compared to the study group (4.7% 
versus 0.8%, respectively; p=0.001). 
Also, the incidence of TTN was 
significantly higher in the control group 
compared to the study group (14.9% 
versus 2%, respectively; p=0.001).  
Indications for NICU admission were 
RDS and some cases of TTN. All cases 
(15 neonates) of RDS were admitted to 
NICU, of whom 12 required mechanical 
ventilator, and 3 responded to 
continuous positive airway pressure 
ventilation (CPAP). On the contrary, 
only cases with severe TTN were 
admitted to NICU (27 cases) and the 
rest of them responded to only oxygen 
therapy on the resuscitator. No cases 
required mechanical ventilation. 
The number of neonates admitted to 
NICU was significantly higher in the 
control group than the study group 
(p=0.003). The same was observed in 
the number of neonates who needed 
mechanical ventilation or CPAP in the 
first 24 hours after birth due to 
respiratory complications (p=0.027, 
0.0001, respectively) (Table 2). 
Discussion 
The current study evaluated the effect of 
the use of prophylactic dexamethasone 
before elective CS at term on neonatal 
respiratory morbidity. The results show 
significant improvement in neonatal 
respiratory condition after administration 
of dexamethasone with less frequent 
admission to NICU and use of 
mechanical ventilation.  
As a result of the rapid rise in the rate of 
CS, especially in developing countries 
such as Egypt in the last years, there is 
a critical need for studying the 
complications of CS, especially those 
associated with neonatal respiratory 
morbidity. When infants are delivered at 
term especially by elective CS before 
the onset of labor pains, they are usually 
deprived of necessary hormonal 
changes, resulting in the development of 
respiratory complications especially 
neonatal RDS.12 
CS is a well-known risk factor for 
neonatal respiratory morbidity, mostly 
TTN and RDS in infants near term.13,14 
But, other confounding factors may 
contribute to the development of 
neonatal respiratory morbidities after CS 
such as the type of anesthesia, neonatal 
gender, weight, and antenatal maternal 
medical disorders.15 In our study, we 
excluded women with medical disorders, 
and all elective cesarean sections were 
done under spinal anesthesia. Besides 
that, there were no significant 
differences between both groups with 
regard to neonatal weight or gender. 
Several mechanisms have been 
postulated for how the use of antenatal 
corticosteroids at term prevents 
neonatal respiratory morbidities. They 
may act by promoting the molecular 
mechanisms that allow alveolar fluid 
drainage. This might be a predominantly 
lung epithelial sodium channels 
mechanism. They may also increase the 
responsiveness to catecholamines and 
thyroid hormones.16 
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A Cochrane systemic review (2009) on 
the prophylactic administration of 
corticosteroids before elective CS at 
term concluded that there was no 
significant difference between women 
who received betamethasone as 
compared to those did not with regard to 
the incidence of RDS, TTN and the 
need for mechanical ventilation. There 
was a significant decrease in the 
incidence of neonatal admission to 
NICU (RR=0.15). The study concluded 
the great need of more studies to further 
clarify this issue.2 
In 2014, a randomized controlled study 
by Nabhan and colleagues in Egypt of 
123 women showed that prophylactic 
administration of 4 doses of 12 mg 
dexamethasone 48 hours before 
elective CS performed at gestational 
age between 34-37 weeks was not 
superior to noprophylaxis.17 There was 
no significant difference in the incidence 
of RDS (p=0.699), TTN (p=0.612), 
admission to NICU (p=0.535) or the 
need for mechanical ventilation (p=509). 
These results are in contrast to our 
results; it should be noted that the dose 
of dexamethasone used was different 
and the gestational age at elective CS 
was earlier than our study. The 
difference in the dexamethasone dose 
and the gestational age of the study 
participants, as well as the larger 
sample size in the current study, may be 
behind the differences in our results. 
In 2011, a study was conducted in Brazil 
by Porto et al. on 273 women. They 
reported in a randomized triple-blind, 
placebo-controlled study that 
betamethasone given at the daily dose 
of 12 mg for 2 days did not reduce the 
incidence of respiratory disorders in 
newborn infants.18 Again, their results 
were different from our study, though it 
is of note that this study had a different 
methodology than ours. Specifically, 
Porto et al. included all deliveries 
between 34-36 weeks whether born 
vaginally or by CS; additionally, a 
different type of corticosteroid was used. 
On the contrary, an earlier study in 1995 
by Morrison et al.19 reported that the 
incidence of respiratory morbidity was 
significantly higher in women delivered 
by elective CS (35.5/1000) compared 
with CS during labor (12.2/1000) 
(OR=2.9; 95% CI=1.9-4.4; P<0.001). 
They found that prophylactic use of 
betamethasone in that group of women 
before elective CS at term reduces the 
risk of respiratory morbidity.  
In 2015, a large RCT was conducted in 
Egypt by Nada et al. to determine 
whether prophylactic dexamethasone in 
a dose of 8 mg/12 hours for 3 doses 
over 48 hours before elective CS at term 
would decrease the neonatal respiratory 
morbidity.20 They found that the NICU 
admission rate was significantly lower in 
the dexamethasone group compared 
with the control group (3.1% versus 
6.7%, respectively; p=0.003). These 
results are in accord with the current 
study as the rate of NICU admission 
was 2.8% in the dexamethasone and 
12.7% in control groups (p=0.003). The 
rate of TTN was significantly lower in the 
dexamethasone group compared with 
the control group (1.3% versus 3.4%, 
respectively; p=0.014).20Our study 
agreed with their results as the rate of 
TTN was 2% versus 14.9% in the 
dexamethasone versus control groups, 
respectively (p=0.001). However, in 
contrast to the present study, 
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prophylactic dexamethasone did not 
significantly reduce the incidence of 
RDS or the need for mechanical 
ventilation in the Nada et al. study 
(p=0.103, 0.127 respectively).20 
Keeping with our results, a recent study 
in 2016 by Gyamfi-Bannerman and 
colleagues confirmed that administration 
of betamethasone to women at 34-36 
weeks gestation significantly reduced 
the rate of TTN and surfactant use.21 
The main strength of the current study 
was the use of dexamethasone which is 
inexpensive, has no major side effects 
or complications, and has proven 
benefits. The large sample size of 
included women in the current study is 
another merit. 
The main limitation of our study was its 
design as a non-randomized study, not 
a randomized controlled trial (RCT). 
Also, we did not compare the neonatal 
outcome at different gestational ages 
after 37 weeks to determine the most 
beneficial time for dexamethasone 
administration. Further studies are 
needed to confirm our results and to 
compare the effects of dexamethasone 
at different gestational ages after 37 
weeks.  
In conclusion, prophylactic 
dexamethasone administration 48 hours 
before elective CS at term after 37 
weeks reduces the rates of neonatal 
respiratory morbidity as well as the 
incidence of NICU admission. 
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